Harnessing pharmacogenomics to tackle resistance to the "nucleoside reverse trancripatse inhibitor" backbone of highly active antiretroviral therapy in resource limited settings (Q37410853)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Harnessing pharmacogenomics to tackle resistance to the "nucleoside reverse trancripatse inhibitor" backbone of highly active antiretroviral therapy in resource limited settings |
scientific article |
Statements
1 reference
Harnessing pharmacogenomics to tackle resistance to the "nucleoside reverse trancripatse inhibitor" backbone of highly active antiretroviral therapy in resource limited settings (English)
1 reference
Misaki Wayengera
1 reference
Henry Kajumbula
1 reference
Wilson Byarugaba
1 reference
1 reference
5 November 2008
1 reference
1 reference
Identifiers
1 reference